These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 20515335

  • 1. Upregulation of SOX2, NOTCH1, and ID1 in supratentorial primitive neuroectodermal tumors: a distinct differentiation pattern from that of medulloblastomas.
    Phi JH, Kim JH, Eun KM, Wang KC, Park KH, Choi SA, Kim YY, Park SH, Cho BK, Kim SK.
    J Neurosurg Pediatr; 2010 Jun; 5(6):608-14. PubMed ID: 20515335
    [Abstract] [Full Text] [Related]

  • 2. Expression of neurogenic basic helix-loop-helix genes in primitive neuroectodermal tumors.
    Rostomily RC, Bermingham-McDonogh O, Berger MS, Tapscott SJ, Reh TA, Olson JM.
    Cancer Res; 1997 Aug 15; 57(16):3526-31. PubMed ID: 9270024
    [Abstract] [Full Text] [Related]

  • 3. MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.
    Grotzer MA, Hogarty MD, Janss AJ, Liu X, Zhao H, Eggert A, Sutton LN, Rorke LB, Brodeur GM, Phillips PC.
    Clin Cancer Res; 2001 Aug 15; 7(8):2425-33. PubMed ID: 11489822
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of intracranial cerebrospinal fluid cytology in staging pediatric medulloblastomas, supratentorial primitive neuroectodermal tumors, and ependymomas.
    Terterov S, Krieger MD, Bowen I, McComb JG.
    J Neurosurg Pediatr; 2010 Aug 15; 6(2):131-6. PubMed ID: 20672933
    [Abstract] [Full Text] [Related]

  • 5. Primitive neuroectodermal tumors of the cerebrum and cerebellum: absence of t(11;22) translocation by RT-PCR analysis.
    Jay V, Pienkowska M, Becker L, Zielenska M.
    Mod Pathol; 1995 Jun 15; 8(5):488-91. PubMed ID: 7675766
    [Abstract] [Full Text] [Related]

  • 6. Sox2 expression in brain tumors: a reflection of the neuroglial differentiation pathway.
    Phi JH, Park SH, Kim SK, Paek SH, Kim JH, Lee YJ, Cho BK, Park CK, Lee DH, Wang KC.
    Am J Surg Pathol; 2008 Jan 15; 32(1):103-12. PubMed ID: 18162777
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from medulloblastomas.
    Pfister S, Remke M, Toedt G, Werft W, Benner A, Mendrzyk F, Wittmann A, Devens F, von Hoff K, Rutkowski S, Kulozik A, Radlwimmer B, Scheurlen W, Lichter P, Korshunov A.
    Genes Chromosomes Cancer; 2007 Sep 15; 46(9):839-51. PubMed ID: 17592618
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High promoter hypermethylation frequency of p14/ARF in supratentorial PNET but not in medulloblastoma.
    Inda MM, Muñoz J, Coullin P, Fauvet D, Danglot G, Tuñón T, Bernheim A, Castresana JS.
    Histopathology; 2006 Apr 15; 48(5):579-87. PubMed ID: 16623784
    [Abstract] [Full Text] [Related]

  • 12. Aberrant hypermethylation of the major breakpoint cluster region in 17p11.2 in medulloblastomas but not supratentorial PNETs.
    Frühwald MC, O'Dorisio MS, Dai Z, Rush LJ, Krahe R, Smiraglia DJ, Pietsch T, Elsea SH, Plass C.
    Genes Chromosomes Cancer; 2001 Jan 15; 30(1):38-47. PubMed ID: 11107174
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Absence of detectable alterations in the putative tumor suppressor gene BTRC in cerebellar medulloblastomas and cutaneous basal cell carcinomas.
    Wolter M, Scharwächter C, Reifenberger J, Koch A, Pietsch T, Reifenberger G.
    Acta Neuropathol; 2003 Oct 15; 106(4):287-90. PubMed ID: 12898158
    [Abstract] [Full Text] [Related]

  • 15. [Different hypermethylation status of RASSF1A in medulloblastoma and supratentorial primitive neuroectodermal tumor].
    Chang Q, Ng HK.
    Zhonghua Bing Li Xue Za Zhi; 2007 Jan 15; 36(1):24-8. PubMed ID: 17374234
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utility.
    Frühwald MC, O'Dorisio MS, Dai Z, Tanner SM, Balster DA, Gao X, Wright FA, Plass C.
    Oncogene; 2001 Aug 16; 20(36):5033-42. PubMed ID: 11526488
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.